Nutritional Management of Chronic Pancreatitis

Initial Assessment and Screening

All patients with chronic pancreatitis should be considered at nutritional risk and screened accordingly 1
Assess for vitamin D deficiency specifically, as 58-78% of chronic pancreatitis patients are deficient 2
Monitor water-soluble vitamins including thiamine, and minerals including magnesium, iron, selenium, and zinc 2

Implement a high-protein, high-energy diet distributed across 5-6 small meals daily 2
Protein intake should be 1.0-1.5 g/kg body weight per day 2
Energy intake should be 25-35 kcal/kg body weight per day 3
Do not restrict dietary fat unless steatorrhea symptoms cannot be controlled with adequate pancreatic enzyme replacement therapy (PERT) 2

Initiate PERT immediately, as it is the most important supplement for patients with pancreatic exocrine insufficiency 2
Use pH-sensitive, enteric-coated microspheres (mini-microspheres 1.0-1.2 mm diameter have higher efficacy) 2
If malabsorption persists despite adequate enzyme supplementation, add medium-chain triglycerides (MCT) 2

Supplement vitamin D: oral 38 μg (1520 IU)/day or intramuscular 15,000 μg (600,000 IU) if deficient 2
Supplement other fat-soluble vitamins (A, E, K) only if deficiency is documented 2
Monitor and supplement magnesium, iron, selenium, and zinc if deficiencies detected 2

Prescribe 5-6 small, frequent meals throughout the day rather than 3 large meals 2
More than 80% of chronic pancreatitis patients can be managed with normal food supplemented by pancreatic enzymes 4, 5

Add oral nutritional supplements when dietary intake alone is insufficient 4, 5
Approximately 10-15% of chronic pancreatitis patients require oral nutritional supplements 4, 5

Consider tube feeding if oral nutrition is not possible due to persistent pain for more than 5 days 4
Enteral nutrition is indicated in approximately 5% of chronic pancreatitis patients 4, 5
Use semi-elemental enteral formulas with MCTs for jejunal nutrition 2

Use parenteral nutrition only in case of GI-tract obstruction or as a supplement to enteral nutrition 3, 6

Failure to recognize pancreatic exocrine insufficiency can lead to malnutrition and fat-soluble vitamin deficiencies 2
Unnecessary fat restriction can lead to inadequate caloric intake and worsening malnutrition 2
Blind vitamin supplementation can lead to vitamin toxicity, particularly vitamin A 2
Poor PERT adherence can lead to persistent malnutrition despite prescription 2
Ignoring altered gut microbiota can contribute to malabsorption 2
Inadequate monitoring of bone health can lead to osteoporosis and increased fracture risk 1

The European Society for Clinical Nutrition and Metabolism recommends that patients with chronic pancreatitis consume approximately 30-33% of total energy from fat, which is well tolerated and associated with improvements in nutritional status and pain control 7
Fat restriction is only necessary if steatorrhea symptoms persist despite adequate pancreatic enzyme replacement therapy (PERT) and exclusion of bacterial overgrowth, according to the European Society for Clinical Nutrition and Metabolism 7
The American Gastroenterological Association suggests avoiding very high fiber diets as they increase flatulence, fecal weight, and fat losses 8

The European Society for Clinical Nutrition and Metabolism recommends screening for deficiencies in vitamins A, D, E, and K at least every 12 months (more frequently in severe disease) 7
The American Gastroenterological Association advises against relying solely on BMI for nutritional assessment as it fails to detect sarcopenia in obese patients with chronic pancreatitis 7

Nutritional intervention with adequate PERT and dietary counseling is associated with reduced pain and improved quality of life, according to the European Society for Clinical Nutrition and Metabolism 7